Harsh Goel
Impact in
-
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
-
- Epigenetics and DNA Methylation 5
- Cancer-related gene regulation 2
- RNA modifications and cancer 2
-
- Acute Myeloid Leukemia Research 3
- Co-authors
- Pranay Tanwar (17 shared papers)Anita Chopra (9 shared papers)Pratibha Pandey (6 shared papers)Birendra Kumar (1 shared paper)Tarun Kumar Upadhyay (6 shared papers)Fahad Khan (6 shared papers)Aditya Gupta (4 shared papers)Goura Kishor Rath (3 shared papers)
- Journals
- Medicine in Drug Discovery (1 paper)CNS & Neurological Disorders - Drug Targets (1 paper)Cancer Cell International (1 paper)Frontiers in Nutrition (1 paper)International Journal of Surgery (1 paper)
- Partner nations
- IndiaUnited StatesSaudi Arabia
In The Last Decade
Harsh Goel
27 papers receiving 228 citations
Peers
Comparison fields: 5 of 84
- Drug Discovery 1
- Hematology 33
- Microbiology 2
- Cancer Research 27
- Genetics 14
Countries citing papers authored by Harsh Goel
This map shows the geographic impact of Harsh Goel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harsh Goel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harsh Goel more than expected).
Fields of papers citing papers by Harsh Goel
This network shows the impact of papers produced by Harsh Goel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harsh Goel. The network helps show where Harsh Goel may publish in the future.
Co-authors
The 25 scholars most cited alongside Harsh Goel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Molecular and genomic landscapes in secondary & therapy related acute myeloid leukemia. | 2021 | 25 |
| 2 | 2023 | 22 | |
| 3 | 2021 | 21 | |
| 4 | 2024 | 19 | |
| 5 | 2022 | 17 | |
| 6 | RECENT DEVELOPMENTS IN CANCER THERAPY BY THE USE OF NANOTECHNOLOGY | 2009 | 15 |
| 7 | Acute myeloid leukemia: novel mutations and their clinical implications. | 2023 | 11 |
| 8 | 2021 | 10 | |
| 9 | 2021 | 9 | |
| 10 | 2021 | 9 | |
| 11 | 2022 | 8 | |
| 12 | Molecular update on biology of Wilms Tumor 1 gene and its applications in acute myeloid leukemia. | 2020 | 8 |
| 13 | 2021 | 7 | |
| 14 | 2020 | 7 | |
| 15 | 2022 | 7 | |
| 16 | An updated account on molecular heterogeneity of acute leukemia. | 2021 | 6 |
| 17 | 2021 | 5 | |
| 18 | 2021 | 5 | |
| 19 | 2023 | 4 | |
| 20 | 2022 | 3 |
About Harsh Goel
Harsh Goel is a scholar working on Molecular Biology, Hematology, Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 231 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), Acute Myeloid Leukemia Research (3 papers), Cancer-related gene regulation (2 papers), Carcinogens and Genotoxicity Assessment (2 papers), COVID-19 Clinical Research Studies (2 papers), RNA modifications and cancer (2 papers), Nanoplatforms for cancer theranostics (1 paper) and Biomarkers in Disease Mechanisms (1 paper). The work is most often cited by research in Drug Discovery (1 citation), Hematology (33 citations), Microbiology (2 citations), Cancer Research (27 citations) and Genetics (14 citations). Harsh Goel has collaborated with scholars based in India, United States and Saudi Arabia. Frequent co-authors include Pranay Tanwar, Anita Chopra, Pratibha Pandey, Birendra Kumar, Tarun Kumar Upadhyay, Fahad Khan, Aditya Gupta, Goura Kishor Rath, Showket Hussain and Abhimanyu Kumar Jha. Their work appears in journals such as Medicine in Drug Discovery, CNS & Neurological Disorders - Drug Targets, Cancer Cell International, Frontiers in Nutrition and International Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.